Wnt Scientific LLC

11:00 AM - 11:15 AM (PDT), Wednesday, June 15, 2022
Wnt Scientific is a preclinical stage company developing the therapeutics for joint diseases. The lead products are StemGel for osteoarthritis and TenGel for tendon injury. The products showed robust efficacy in animal studies. The MOA of StemGel is to inject a protein that specifically inhibits Wnt signaling to the joint cavity to suppress inflammation and stimulate cartilage regeneration. We have developed the CHO cell line to scale-up the peptide production. TenGel is the small molecules encapsulated in hydrogel that is topically used to the tendon tear site to stimulate tendon stem cell proliferation and differentiation. For TenGel, we have demonstrated the safety profile and investigated the pK of the APIs. The company also developed a pipeline for nonunion fracture and critical size bone defect repair.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
New York
Company HQ Country:
United States
Year Founded:
2017
Main Therapeutic Focus:
Lead Product in Development:
StemGel for osteoarthritis, TenGel for tendon injury
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided